← Back to Search

Outreach Intervention for Depression

N/A

Waitlist Available

Research Sponsored by Kaiser Permanente

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 60 days of randomization

Awards & highlights

Study Summary

This trial is looking at ways to help racial and ethnic minority populations get treatment for depression, to reduce health disparities.

Who is the study for?

This trial is for adults with a new diagnosis of major depression or dysthymic disorder who haven't started treatment. They must have been part of the health system for a year, not use antidepressants or therapy in the last 30 days, and have moderate to severe symptoms. It's not for those without EHR portal access, who opted out of research contact, or with recent schizophrenia or bipolar diagnoses.Check my eligibility

What is being tested?

The study tests if outreach messages can help people from underserved racial and ethnic groups start treating their depression. It compares different communication methods (online messaging, mail, phone) to see which works best without widening health disparities.See study design

What are the potential side effects?

Since this trial focuses on outreach messaging rather than medication or invasive procedures, there are no direct physical side effects expected from participating in the study.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 60 days of randomization

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 60 days of randomization

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 60 days of randomization for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Mental Depression

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Outreach MessagingExperimental Treatment1 Intervention

Participants in the outreach messaging arm will receive messages via online secure message system (embedded within the health care record) and/or telephone.

Group II: Usual CareActive Control1 Intervention

Participants assigned to usual care will not receive outreach messages (online or via telephone) by study staff.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Kaiser PermanenteLead Sponsor

538 Previous Clinical Trials

24,113,428 Total Patients Enrolled

35 Trials studying Depression

120,484 Patients Enrolled for Depression

Henry Ford Health SystemOTHER

300 Previous Clinical Trials

2,099,599 Total Patients Enrolled

7 Trials studying Depression

4,038 Patients Enrolled for Depression

Media Library

Outreach Messaging Clinical Trial Eligibility Overview. Trial Name: NCT05580406 — N/A

Depression Research Study Groups: Usual Care, Outreach Messaging

Depression Clinical Trial 2023: Outreach Messaging Highlights & Side Effects. Trial Name: NCT05580406 — N/A

Outreach Messaging 2023 Treatment Timeline for Medical Study. Trial Name: NCT05580406 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment still open for this trial?

"Clinicaltrials.gov states that this particular trial, which started recruiting on April 13th 2023 and stopped accepting patients on August 22nd 2023, is no longer actively seeking participants. However, there are over 1,362 other clinical studies currently enrolling individuals at the moment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Outreach to Reduce Depression Disparities

2023. "Outreach to Reduce Depression Disparities". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05580406.